Health, Education & Government Government & Public Sector Public Health & Human Services

Public Health Informatics

Multi-agency, multi-stakeholder programs where procurement, compliance, and mission alignment determine success.

Example organizations in this space: Oracle Cerner Epic Rhapsody Arcadia

This interactive experience is the shipped product itself — the same application code customers run in production, mounted read-only in your browser over a real sample journey. Not a video, not a mockup: because the demo and the product are one codebase, it can never drift from the real thing.

Inside this journey
  1. Outcome Discovery

    Align on surveillance goals, current systems, reporting requirements, stakeholders, and measurable success signals.

    Discovery Questions

    Starting Point: Your Surveillance Priorities

    • Tell me about the top surveillance priority your team is accountable for right now.
    • How many data sources feed the systems you use today, counting hospitals, labs, immunization providers, and vital records? Options: 1-5, 6-20, 21-50, 51-100, 100+
    • When was the last time federal reporting requirements forced you to change a workflow or submit a one-off file? Options: Within last 3 months, 3-6 months ago, 6-12 months ago, More than a year ago, Never
    • Who on your team is the day-to-day owner for surveillance data quality and reporting? Options: Epidemiologist, CIO or IT director, Informatics lead, Data manager, Other
    • Describe the reporting cadence you must meet for CDC and state-level reports. Options: Daily, Weekly, Monthly, Quarterly, Ad hoc
    • Which stakeholders find incomplete or delayed data most costly to their work? Options: Epidemiology program leads, CIO/IT team, Laboratory directors, Clinical partners, State leadership, Federal reporting office

    Where Your Current System Falls Short

    • What single operational failure in your current surveillance stack would make you pause a procurement today?
    • If that failure happens, who is first to notice and how is it typically reported? Options: Program email/alert, Phone call to IT, Ticket in help desk, Noticed in monthly review, Other
    • Walk me through a recent incident where reporting or case management broke down, and its downstream impact.
    • How do you measure the time from a lab result arriving to it appearing in your case management view? Options: Automated metric, Manual audit, Ad hoc checks, Not measured
    • On average, how many manual interventions are required per day to reconcile incoming lab feeds? Options: 0-5, 6-20, 21-50, 51-100, 100+

    What's Getting in the Way of Reliable Reporting

    • Which integration gap causes the most missed or duplicate reports in your environment? Options: Missing lab HL7 feeds, Inconsistent immunization records, No FHIR endpoints from partners, Duplicate case creation, Other
    • Are there data formats or interfaces your partners cannot produce reliably today? Options: HL7 v2 inconsistent, FHIR not available, Flat files with variable schema, Paper or fax-only partners, No major format issues
    • Who controls the integration endpoints at your major lab and hospital partners? Options: External partner IT, Internal integration team, Third-party vendor, Unknown
    • Provide the formats and accessibility status for the datasets to be migrated, noting any known schema differences.
    • Outline the fallback options that would keep the project alive if a data-sharing agreement misses your target window. Options: Scoped pilot with limited data, Synthetic or de-identified data, Staged rollouts by partner, Project pause

    Alternatives You Are Considering

    • Why would your team prefer to stay with the current approach rather than change to an external platform?
    • List the alternatives you have evaluated or are still evaluating, including the incumbent, other vendors, and internal build. Options: Incumbent vendor, Another vendor, Internal build, Open source solution, Maintain current systems
    • For any alternative that involves building internally, who has proposed it and what resource commitments would it require?
    • What would have to be true about your current approach for you to decide to stay with it instead of moving forward with the seller?
    • When you consider the internal build path, what is the earliest realistic delivery date you would expect? Options: Within 3 months, 3-6 months, 6-12 months, 12+ months, Unsure

    Can You Meet the Technical and Compliance Gates?

    • Name the single prerequisite that, if unmet, would stop deployment from starting.
    • Identify the named integration owner for each external partner and whether they can approve connection changes. Options: Yes, single owner per partner, Multiple owners across teams, No clear owner, Contractor or third party
    • How many staff hours per week can your team realistically allocate to integration and testing? Options: <5 hours, 5-10 hours, 11-20 hours, 21-40 hours, 40+ hours
    • Provide the availability and format for each dataset the project depends on, including whether data owners have signed access approvals.
    • Are there regulatory reviews, legal approvals, or data use agreements that regularly delay projects, and how long do they typically take? Options: <2 weeks, 2-6 weeks, 6-12 weeks, 12+ weeks
    • Outline your contingency plan if key integration owners cannot provide API access during the planned testing window.

    How You Will Measure Success and Accept Work

    • Assuming a pilot shows the expected reduction in manual reconciliation, what could still prevent you from signing the contract that week?
    • List the three metrics you would require to validate a successful pilot for reporting acceptance. Options: Reduction in manual reconciliation (%), Time to report (hours), Data completeness (%), Duplicate report reduction, Other
    • On average, what reporting latency from lab arrival to public health dashboard is acceptable for you? Options: <1 hour, 1-6 hours, 6-24 hours, 24-72 hours, 72+ hours
    • Identify who signs off on a go-live decision and the specific evidence they require.
    • For each acceptance criterion, indicate whether you require automated validation or manual sampling. Options: Automated validation required, Manual sampling acceptable, Both
    • Rate how critical continuous CDC feed conformity is to initial go-live, using high, medium, low. Options: High, Medium, Low

    Decision Timeline and Political Drivers

    • When a key stakeholder asks how soon you can show measurable value, what date do you give them? Options: Within 30 days, Within 60 days, Within 90 days, Longer than 90 days, Unsure
    • Catalog the internal champions and likely blockers by role and decision authority.
    • Estimate the number of procurement or budget review steps that must be completed before you can sign a vendor contract. Options: 1-2, 3-5, 6-10, 10+
    • Assuming the pilot meets its targets, who can approve an expedited purchase and do they have budget authority now? Options: Yes, budget authority now, Yes, after sign-off, No, requires additional approval, Unknown
    • Explain the amount of timeline slippage that would be fatal to your funding window.

    Commitment Signals and Next Steps

    • Suppose the pilot demonstrates the key metrics, what would still prevent you from committing within your quarter?
    • Name the roles the seller should list as owners on the project plan for the first 90 days. Options: Project manager, Integration lead, Product owner, Clinical lead, Data steward
    • How often do you want status updates during integration testing, and which format do you prefer? Options: Weekly written, Twice weekly written, Weekly standup (video), Daily digest email, Ad hoc on request
    • When you think about post-live support, how many months of hypercare would you expect to include in the initial contract? Options: 0-1 months, 1-3 months, 3-6 months, 6+ months
    • What reporting or data access commitments would accelerate your procurement if they were included in the contract?
    • Are you prepared to assign a named buyer owner who can make budget decisions within 30 days of a successful pilot? Options: Yes, Maybe, No
  2. Solution Experience

    Walk through how the platform will integrate laboratory, clinical, and vital records data to meet reporting mandates and operational workflows using the buyer's scenarios.

    Solution Experience

    • Solution Experience: Integrating Laboratory, Clinical, and Vital Records
    • Confirm the current state and its cost
    • You confirm the demonstrated workflow eliminates the manual reconciliation and reduces time to report for the shown scenario.
    • Provide sample HL7/FHIR messages and a representative extract of clinical and vital records for the two priority scenarios to be run in the POE environment.
    • You agree the displayed field mappings satisfy the CDC reporting elements for the scenario or identify the exact mapping gaps remaining.
    • Walk an end-to-end buyer scenario
    • Deliver a scenario run report and a mapping spreadsheet that shows field-level transformations and missing elements for buyer review within 5 business days.
    • Show how fields map to reporting mandates
    • You agree on the technical owners and acceptance criteria needed to advance to configuration and scope.
    • Identify the integration endpoint owners and a test partner contact for each data source required for the validated scenario.
    • Confirm integration responsibilities and cutover approach
    • Validation, confirm this matches what you meant
    • Solution Experience: Integrating Laboratory, Clinical, and Vital Records
    • Solution Experience Deck
    • Solution Brief
    • meeting
    • slides
    • document
  3. Solution Scope

    Define modules (ELR, syndromic, IIS, case management), data migration and mapping needs, integration endpoints, responsibilities, and acceptance criteria.

    Scope Configuration

    • Configure HL7 Lab Interfaces
    • Set Up FHIR Clinical Endpoints
    • Onboard Flat-File Data Feeds
    • Integrate Hospital ADT Feeds
    • Connect State Lab Information Systems
    • Deploy Syndromic Surveillance Ingest
    • Migrate Immunization Registry Data
    • Migrate Vital Records and Birth/Death Data
    • Deploy Reportable Condition Case Management
    • Configure CDC and State Automated Reporting
    • Map and Normalize Clinical Code Sets
    • Train Users and Provision Role Access
    • Ongoing Platform Maintenance and Standards Updates

    Scope Questions

    Configure HL7 Lab Interfaces

    • List the sending laboratory systems (hospital lab, reference lab, public health lab) that will connect via HL7 ELR to your integration endpoint Options: Hospital laboratory, Commercial/reference laboratory, State public health laboratory, Other
    • Provide the HL7 v2 message types and trigger events you expect from each lab (for example ORU^R01 for results, R01/ORU details)
    • How many ELR messages per day do you expect from each sender system Options: Under 100, 100-1,000, 1,000-10,000, 10,000+
    • Estimate the percentage of lab results that include standard LOINC codes versus local/test-specific codes Options: 0-25%, 25-50%, 50-75%, 75-100%
    • Identify the secure transport methods your labs can support for HL7 v2 (select all that apply) Options: MLLP over TLS, SFTP (batch files), HTTPS webservice, Other
    • Which acceptance criteria will confirm successful ELR ingestion and normalization (for example parsing success rate, LOINC mapping coverage, and timely arrival window) Options: >99% parse success, >95% required LOINC mapping coverage, Median delivery within 4 hours, Manual validation of 50 sample records

    Set Up FHIR Clinical Endpoints

    • List the EHRs or clinical systems that will expose FHIR endpoints to the platform
    • Provide the FHIR resources you require the endpoints to support (for example Patient, Observation, Immunization, Condition) Options: Patient, Observation, Immunization, Condition, Encounter, Other
    • How many historical clinical records (approximate patient counts) do you plan to extract via FHIR bulk or individual resource reads Options: <1,000 patients, 1,000-10,000, 10,000-100,000, 100,000+
    • Specify the FHIR version and profiles your partners currently support (for example R4, US Core profiles) Options: R4 (US Core), R4 (custom profiles), DSTU2/R3, Not sure
    • Indicate the authentication/authorization method for FHIR endpoints you expect to use Options: OAuth2 (SMART on FHIR), Mutual TLS, API key, Other
    • Describe the method you will use for patient matching on FHIR resources (for example probabilistic match on name/DOB/SSN or existing state identifier)

    Onboard Flat-File Data Feeds

    • Name the sources that will deliver flat-file extracts (for example laboratory CSV, vital records pipe-delimited files) and the producing system for each
    • Provide the file formats and schema types you receive today (for example CSV with headers, fixed-width, HL7-derived pipe-delimited) Options: CSV with headers, Pipe-delimited, Fixed-width, XML, Other
    • How frequently are flat-file extracts produced by each source (for example daily batch at 03:00, hourly) Options: Hourly, Daily, Weekly, Ad-hoc
    • Specify the secure delivery method you will use for flat files to the integration endpoint Options: SFTP, AS2, HTTPS POST, Manual upload
    • Are there PHI redaction or de-identification rules that must be applied to flat files before ingestion (for example redact SSN, mask address) Options: Yes - predefined fields, No, Partial - case-by-case
    • How will you validate row- and field-level mappings for flat-file imports (for example sample file mapping sign-off, schema validation report)

    Integrate Hospital ADT Feeds

    • Identify the hospitals or health systems that will supply ADT feeds and the receiving interface endpoints
    • Provide the HL7 ADT event types and versions expected (for example ADT^A01, ADT^A03, HL7 v2.5.1) Options: ADT A01/A03/A08 (v2.5.1), ADT A01/A03 only, Other versions
    • How many ADT messages per day do you anticipate from each hospital Options: Under 1,000, 1,000-10,000, 10,000-50,000, 50,000+
    • Describe how ADT identifiers (medical record number, visit number) should map to your state/local patient identifiers
    • Are there custom Z-segments or non-standard segments in your ADT messages that require mapping (for example local allergy segment or bed assignment Z-seg) Options: Yes - custom segments present, No - standard only, Unsure - need to inspect sample messages
    • Who on your team will be the technical owner for ADT feed onboarding and ongoing monitoring

    Connect State Lab Information Systems

    • List the state lab system endpoints and the interface protocols they support (for example HL7 v2 MLLP, SFTP, FHIR API)
    • Provide any state-specific envelope or PHIN messaging requirements we must follow for lab exchanges Options: PHIN profile required, Standard HL7 v2 only, State-specific envelope
    • How often does the state lab publish result batches or allow queries (for example real-time, hourly batch, daily) Options: Real-time, Hourly batch, Daily batch, Ad-hoc
    • Specify the technical contact at the state lab for integration testing and ongoing problem resolution
    • Are there mandated audit or acknowledgement workflows for state lab results (for example NACK/ACK handling, automated retransmit) Options: Standard ACK required, Custom ack/retry workflow, None specified
    • How will we track and reconcile missing or rejected lab messages from the state LIS (for example daily reconciliation report)

    Deploy Syndromic Surveillance Ingest

    • Identify the emergency departments and urgent care sites that will submit syndromic surveillance feeds
    • Provide the expected HL7 message types, chief complaint fields, and diagnosis vocabularies used (for example ICD-10, SNOMED CT) in sender messages Options: ICD-10, SNOMED CT, Local codes, Other
    • Specify the near-real-time latency requirement for syndromic data ingestion (for example within 1 hour of encounter) Options: Within 15 minutes, Within 1 hour, Within 6 hours, Daily batch
    • Describe any syndrome definitions or case rules you need applied on ingestion (for example respiratory syndrome per CDC NSSP definitions)
    • Do you require natural language processing or chief-complaint normalization to support syndrome classification Options: Yes - NLP required, No - structured fields only, Optional
    • How will you measure classification accuracy during testing (for example percent agreement with manual review)

    Migrate Immunization Registry Data

    • List the legacy immunization registry exports available for migration and approximate record counts
    • Provide the vaccine coding systems in use in your registry (for example CVX codes, MVX, NDC) and any local codes Options: CVX, MVX, NDC, Local codes
    • Name the fields that must be preserved for each immunization event (for example lot number, administration date, provider, VIS date)
    • Specify your required deduplication and patient-matching threshold for immunization records (for example auto-match at 95% probability) Options: Auto-match at 95% threshold, Auto-match at 90% threshold, Manual review required
    • Which migration acceptance criteria will confirm the immunization data migration is complete (for example field-level mapping coverage >=99%, reconciliation of total immunizations) Options: >=99% field mapping, Reconcile counts within 0.5%, Sample-based clinical validation
    • Who will approve the final migration reconciliation report for the immunization registry

    Migrate Vital Records and Birth/Death Data

    • List the vital records datasets in scope (for example birth certificates, death records) and their originating systems
    • Provide the file formats and schemas for vital records exports (for example XML schema, CSV with specified headers) Options: XML, CSV with headers, Custom fixed-width, Other
    • Specify required field-level validation rules for vital records (for example date of birth format, numeric birth weight range, ICD-10 cause-of-death codes)
    • Describe how linkage between birth records and maternal records must be handled during migration
    • Are there statutory retention, archival, or access restrictions that affect how migrated vital records are stored and accessed Options: Yes - statutory restrictions, No, Partial - some datasets restricted
    • Who is authorized to sign off on data acceptance for migrated birth and death records

    Deploy Reportable Condition Case Management

    • List the notifiable conditions and associated report forms that must be implemented (for example tuberculosis, measles, hepatitis) and any condition-specific fields
    • Provide the case investigation workflows required (for example auto-create from positive ELR, manual case intake, referral routing) Options: Auto-create from ELR, Manual intake, Referral routing, Other
    • What evidence will validate case creation and report submission workflows are accepted (for example executed test cases, automated submission receipts to state endpoint) Options: Successful test case run, Receipt acknowledgement from receiving endpoint, Sample clinical validation
    • Describe how lab results should link to existing or new cases (for example link by patient match + condition code within 14 days)
    • Specify notification and escalation timelines for case triage and contact tracing actions Options: Within 24 hours, Within 48 hours, Custom timeline
    • Who will own case closure criteria and retention policies once case management is live

    Configure CDC and State Automated Reporting

    • List the automated reporting targets required (for example NNDSS, state immunization reporting, ELR to CDC/state) and the data feeds that feed each target
    • Provide the submission formats and schedules required by each reporting authority (for example daily HL7, weekly aggregate CSV) Options: Real-time HL7, Daily batch, Weekly summary, Ad-hoc
    • Specify the transport method for automated submissions (for example SFTP push, API with mutual TLS, web portal upload) Options: SFTP push, API (HTTPS/mTLS), Web portal upload, Other
    • Describe the reconciliation and acknowledgement workflow you require for automated reports (for example automated resend on NACK, daily reconciliation log)
    • Are there state privacy or data-minimization rules that change the data elements sent to a specific reporting authority Options: Yes - element suppression required, No, Partial
    • What retry and SLA thresholds should automated reporting adhere to (for example 3 retry attempts over 24 hours) Options: 3 retries over 24 hours, 5 retries over 72 hours, Custom
  4. Mutual Commit

    Finalize commercial and legal terms, data-sharing and privacy obligations, timelines, and mutual responsibilities required for compliant implementation.

    Agreement Modules

    • Master Services Agreement (MSA)
    • Statement of Work (SOW)
    • Subscription Order Form
    • Service Level Agreement (SLA)
    • Data Processing & Privacy Addendum (DPA / HIPAA BAA)
    • Procurement & Security Addendum
    • Acceptance Certificate & Go-Live Agreement
    • Change Order Agreement
  5. Deployment

    Lock readiness facts and configuration values before execution begins.

    1. Pre-Deployment Readiness

      Confirm environments, data access authorizations, integration owners, test partners, and timeline dependencies the deployment depends on.

      Pre-Deployment Questions

      Environment and site access

      • Which environments will be used for this deployment? Select all that apply (use the environment labels your team uses so we schedule correctly). Options: Production, Staging / UAT, Sandbox, Legacy on‑prem / data center, Test / integration lab, Other (describe below)
      • Is the production environment accessible to the seller's deployment team today? If not, please provide the expected availability date (so we can schedule cutover and smoke tests). Options: Yes — accessible now, No — available by specific date (enter date below), Limited access — only via vendor/third-party, Unknown
      • Are network access, firewall/VPN exceptions, and service account authorizations in place for the seller's deployment IP ranges and users? Options: All authorizations in place, Partial — some exceptions pending (describe below), No — buyer must request, Third‑party controlled — we need assistance coordinating

      Data and configuration

      • Which data domains are in scope for the initial migration/ingestion? Select all that apply. Options: Electronic laboratory reporting (ELR), Syndromic surveillance, Immunization information system (IIS) / immunizations, Vital records, Reportable case management, Other (describe below)
      • For each selected domain, has a named source‑system owner been assigned? Provide the owner's name and role for each domain (these owners will own field mapping and validation sign‑off).
      • Has the field‑mapping approach and migration acceptance criteria been decided (e.g., record/sample counts, validation checks), or do you require seller support to define them? Options: Buyer has fully defined mapping & acceptance criteria, Buyer has partial definitions — seller support needed, No — seller will define with buyer, Unknown / not started

      People and ownership

      • Provide the named integration owner(s) for each integration type (e.g., HL7 inbound lab feeds, FHIR immunization, flat‑file batch loads). Include name and role — these individuals will be the daily technical contacts.
      • Who is the buyer's single point of contact authorized to make go/no‑go decisions and formally accept reporting validation results?
      • Are external test partners (sending labs, hospitals, IIS nodes, or other submitters) confirmed and scheduled for integration testing? Options: Yes — all confirmed and test windows scheduled, Partially — some confirmed, others pending, No — none confirmed, Not applicable — using synthetic/test data only

      Timing and constraints

      • List any schedule constraints we must observe (deployment blackout dates, peak reporting periods, legislative deadlines) and the owner who enforces each constraint.
      • Are regulatory, legal, or privacy approvals required before data onboarding (e.g., data use agreement, privacy office sign‑off)? Indicate status. Options: All approvals obtained, Approvals in progress, Approvals not started, No approvals required / unknown
      • What is the buyer's target initial cutover window or earliest acceptable date range for the deployment? (This helps align seller resources and dependent schedules.)
    2. Configuration Details

      Capture exact integration settings, field mappings, interface credentials, HL7/FHIR endpoints, and migration cutover plans for execution.

      Configuration Details

      ENVIRONMENTS & ENDPOINTS — where the platform will connect

      • Enter the production instance name the platform will use (enter the exact instance identifier shown in the platform admin). Default: prod
      • Enter the production FHIR REST endpoint URL the platform will call (format: https://<host>/fhir — no trailing slash). This value is consumed by the integration connector.
      • Enter the production HL7 v2 listener endpoint the platform will use (format: tcp://host:port or mllp://host:port). This value is consumed by the HL7 adapter.

      AUTHENTICATION & CREDENTIALS (identifiers only — NO SECRETS)

      • Select the authentication method the production FHIR endpoint will use. Default: OAuth2 Options: OAuth2 (client ID), Mutual TLS (cert name), Basic Auth (username), API Key (key name), None
      • Provide the non-secret credential identifier for the chosen method (enter exact client ID, cert name, username, or key name as shown in your IdP or secrets manager). This identifier is used in connector configuration.
      • Select how the secret (client secret/cert/private key) will be exchanged at deployment kickoff — the secret itself will NOT be pasted into this sheet. Options: your secrets manager (customer-controlled), the platform's secure exchange (vendor portal), Encrypted SFTP drop arranged at kickoff, Other — arrange at kickoff

      INTERFACE & FIELD MAPPINGS — exact mapping sources consumed by the build

      • Enter the single URL or filesystem path to the canonical field-mapping file the deployment will ingest (format: https://... or s3://... or file:///full/path — include filename). This file will be applied verbatim.
      • Enter the exact source field name in your system that maps to the platform's primary patient identifier (case-sensitive, exact source label). This single value will populate the mapping table.

      DATA MIGRATION & CUTOVER — concrete dates and counts the migration plan uses

      • Enter the planned migration cutover date (format: YYYY-MM-DD). Default: 90 days after Mutual Commit — confirm or provide a concrete date. This date is used to schedule the cutover run.
      • Enter the estimated number of historical records to migrate (integer; e.g., 125000). Default: 0 if no historical migration. This numeric value drives migration capacity planning.
    3. Deployment

      Execute rollout with named owners, sequenced tasks, validation cycles, and go-live decision criteria tied to reporting acceptance.

  6. Success

    Confirm outcomes against success metrics, capture learnings, and maintain a shared channel for issues and prioritized enhancements.

    Success Reviews

    • Go-live Health Check (weeks 1-4)
    • First Measurement Review (weeks 4-10)
    • Acceptance Gate Meeting (around day 90)
    • Quarterly Success Review (ongoing)

    Issues & Enhancements

    • Schedule implementation windows for approved enhancements and document acceptance criteria for each change.
    • Update field mapping and transformation documentation to reflect agreed fixes.
    • Publish an interim metrics dashboard snapshot for the acceptance gate review.
    • Restate acceptance criteria and numeric targets recorded in Solution Scope
    • Produce a documented acceptance decision for each acceptance criterion recorded in Solution Scope, with pass/fail outcomes captured.
    • For any failed criteria, record a remediation plan with owners and fixed completion dates sufficient to close the acceptance loop.
    • Verify the incumbent system retirement plan is executed or agreed, preventing dual-operation and ensuring data is archived or retained read-only as documented.
    • Publish the acceptance record and outcome evidence to the shared project workspace and archive the meeting record.
    • Create remediation tasks for failed criteria with owners, acceptance retest steps, and firm due dates.
    • Execute the incumbent decommissioning checklist or record the retention/read-only plan and its milestones.
    • Trend review of named metrics versus Solution Scope targets
    • Verify whether CDC reporting completeness (%) and case investigation turnaround time (hours) are on track relative to Solution Scope targets and document any variance.
    • Ensure all high-priority operational issues have owners and committed resolution dates, and confirm the ticket burn-down plan.
    • Agree the priority and timing for any approved enhancements that will affect production behavior or reporting.
    • Publish the quarterly metrics dashboard with notes on variance and planned corrective actions.
    • Create or update remediation tasks for any persistent high-severity tickets with target resolution dates.
    • Re-confirm success criteria and ownership
    • Confirm the deployment completed against the functional checkpoints recorded in Solution Scope and identify any incomplete items.
    • Document all high-priority blockers with owners and target resolution dates.
    • Capture initial adoption signals and list follow-up training or access tasks required.
    • Publish a deployment validation report including record counts, integration statuses, and open defects for async review.
    • Log and assign remediation tasks for each high-priority blocker with target completion dates.
    • Schedule first measurement session within 4-10 weeks to review early outcome data.
    • Present first production data against named metrics
    • Establish whether timely lab report ingestion rate (%) and hours per week spent on manual reporting are moving toward Solution Scope targets and quantify the gap where present.
    • Assign owners and dates for each corrective action required to address root causes of metric gaps.
    • Confirm a clear timeline and criteria for the acceptance gate meeting.
    • Deliver a data-quality ticket list with priority, expected fix date, and the validation test to confirm resolution.
    • Present outcome data against each criterion
    • Operational issues and ticket burn-down
    • Deployment and migration validation
    • Diagnose root causes for metric gaps
    • Document pass/fail per criterion and record acceptance decision
    • Early adoption signals and usage patterns
    • Prioritized enhancements and maintenance backlog
    • Agree corrective actions with owners and dates
    • Risk review and dependencies
    • Agree remediation plan for any failed criteria
    • Open issues and blockers
    • Confirm timeline to the acceptance gate
    • Record data integrity and mapping updates needed
    • Incumbent system decommissioning verification
    • Confirm next steps and cadence
    • Agree immediate remediation actions and next checkpoint
First-Party AI

1-2 minutes please — Your AI agent is working

First-Party AI™ can make mistakes. Always check important information.